Recent Finacing
Recent Raise
FoRx develops small-molecule therapeutics that inhibit novel DNA repair pathways such as Break Induced Replication to exploit cancer-specific vulnerabilities via synthetic lethality, advancing validated BIR targets in preclinical models.
Focus Areas
Recent Investors
Total Raised
Funding round
Investors